Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
US military says it turned away blockade runner trying to reach Iranian port
Jubilant PSG supporters spill onto Paris streets, some clash with police
WHO chief urges safe burials in visit to heart of Ebola outbreak
Rescuers pull four from flooded cave in Laos
